We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Mixed revenue trends emerge from the latest batch of quarterly updates Proteomics plans to launch i...
Read ArticleMedical technology company ImpediMed (ASX:IPD) continues to make strides with its SOZO® Digital Heal...
Read ArticleControl Bionics says it has overcome the “challenges” of the 2023-24 year Ord Minnett identifies th...
Read ArticleThe ASX is anticipated to experience a slight decline at the opening on Tuesday, following Wall Stre...
Read ArticleASX set for slight drop as investors digest Fed comments Fed officials hint at potential future rat...
Read ArticleStockhead joined with IR Department and Morgans for HealthInvest 2024 in Sydney last week The event...
Read ArticleWhen I last covered ImpediMed (ASX:IPD) in May last year, I opined that the time-honoured way of lif...
Read ArticleASX health stocks dropped 1.74% in the past five days, while the broader markets rose 1.55% Power c...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleASX health stocks dropped 1.22% in the past four days, while the broader markets fell 1.35% Morgans...
Read ArticleASX health stocks flat for week in line while broader markets rise of 0.5% Nanosonics has risen ~17...
Read ArticleStockhead joins with IR Department and Morgans for HealthInvest 2024 in Sydney in September Event t...
Read ArticleASX health stocks rise 0.9% in past five days as broader markets lift 1.2%, despite Friday selloff...
Read ArticleThe ASX200 had a strong start to the week rising 0.86% to 7989.60 points – not far off the recently...
Read ArticleASX health stocks fall 0.19% in past five days as broader markets lift 0.79% Morgans says capital r...
Read ArticleEcho IQ is awaiting FDA approval for its AI-powered EchoSolv platform EchoSolv utilises machine lea...
Read ArticleIn 2024 several ASX medtech companies have upcoming catalysts as they strive to innovate healthcare...
Read ArticleASX health stock fall in past five days in line with broader markets as economic and geopolitical f...
Read ArticleHere’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 2...
Read ArticleProvaris Energy has seen its directors strongly support its recent placement Greentech Metals exec...
Read ArticleNew ImpediMed leadership team and board committed to company’s success Private payor and Medicare...
Read ArticleASX health sector lifts in line with broader markets as reporting season comes to end Morgans upgra...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABG)) - Abacus Group ((ABC))...
Read ArticleASX health sector falls broader market with some key names ailing in reporting season CSL Phase III...
Read ArticleASX health sector up in line with broader market but some names ail after quarterly results Cochlea...
Read ArticleASX health stocks flat in past five days in line with broader markets Avita lowers full year 2023...
Read ArticleAfter early gains, ASX200 finished off the day pretty even – up only .13 of a per cent. Energy s...
Read ArticleTwo ASX All Ords shares announced significant changes among their top brass today. And investors re...
Read ArticleASX to open higher on Monday after Wall Street’s third straight weekly gains ChargePoint tumbled -3...
Read ArticleImpediMed makes leadership and board changes to enhance growth and manage costs effectively Rick...
Read ArticleAt the $240 million Perennial Better Future Trust, healthcare stocks are a critical component of our...
Read ArticleASX health stocks rise in past five days in line with broader markets Mach7 Technologies reports re...
Read ArticleThe Australian stock market has surged around midday, buoyed by the positive performance on Wall Str...
Read ArticleTo register for today's webinar click here. Findi (ASX:FND) has extended the existing State Bank o...
Read Article03 Nov 2023 - A snapshot of the stocks on the move, featuring Findi (ASX:FND), Immutep (ASX:IMM) an...
Read ArticleASX health sector falls in line with broader markets as macroeconomic factors continue to create vo...
Read ArticleBod Science confirm the effectiveness of Aqua Phase technology ImpediMed announces new chief medica...
Read Article2023 a case of “haves and have nots” for ASX biotech sector as companies with good catalysts lead t...
Read ArticlePolynovo Ltd (ASX: PNV) shares have struggled to find support in 2023. After a brief reprieve betwe...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIS)) - Aeris Resources ((AGI...
Read ArticleASX healthcare stocks haven’t done so well as a collective over the past 12 months. The S&P/AS...
Read ArticleUS healthcare company, CurveBeam AI, is preparing to debut on the ASX today after concluding its pre...
Read ArticleASX health stocks fall 2.4% in the past five days in line with broader markets Mesoblast crashes mo...
Read ArticleWorld Overnight SPI Overnight 7360.00 – 39.00 – 0.53% S&P ASX 200 7450.70 + 40.30 0.54%...
Read ArticleWorld Overnight SPI Overnight 7383.00 + 25.00 0.34% S&P ASX 200 7410.40 + 6.80 0.09% S&a...
Read ArticleWeekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Wo...
Read ArticleThe S&P/ASX 200 Index (ASX: XJO) is on form again and on track to record a small gain. In aft...
Read ArticleThe Energy sector demonstrated strong growth, with a rally of 1.7%. Ampol (ASX:ALD) experienced a si...
Read ArticleWoodside Energy (ASX:WPL), reported a 29% decline in revenue for the second quarter, amounting to $U...
Read ArticleImpediMed (ASX:IPD) are the first top 5 national payor covering SOZO testing for cancer patients a...
Read Article19 Jul 2023 - A snapshot of the stocks on the move, featuring ImpediMed (ASX:IPD), Imugene Limited (...
Read ArticleWeekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Wo...
Read ArticleWorld Overnight SPI Overnight 7182.00 – 37.00 – 0.51% S&P ASX 200 7253.20 – 25.80 – 0.35%...
Read ArticleWorld Overnight SPI Overnight 7233.00 – 12.00 – 0.17% S&P ASX 200 7279.00 + 32.90 0.45%...
Read ArticleWorld Overnight SPI Overnight 7216.00 – 1.00 – 0.01% S&P ASX 200 7246.10 + 42.80 0.59% S...
Read ArticleClinical validation study confirms efficacy of INOVIQ’s SubB2M/CA15-3 test for breast cancer Ramsa...
Read ArticleShareCafeMiners surge on higher iron ore prices: ASX closes up 1% by Peter Milios At the closing b...
Read ArticleShareCafeAustralia’s inventories increase for March Qtr: ASX 1.05% higher at noon by Peter Milios ...
Read ArticleShareCafeStocks of the Hour: REZ, WA1, IPD Resources & Energy Group (AS...
Read Article05 Jun 2023 - A snapshot of the stocks on the move featuring Resources & Energy Group (ASX:REZ),...
Read ArticleASX health stocks outperforming the broader market but remain flattish for week Several ASX health...
Read ArticleThe market shows that biotechs are making a gradual comeback in 2023 What are some of the catalysts...
Read ArticleASX health stocks have fallen in the past five days in line with broader markets Volpara Health Tec...
Read ArticleEBR announces positive results of its pivotal SOLVE-CRT trial at Heart Rhythm 2023 in US EBR latest...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a positiv...
Read ArticleS&P/ASX 200 closes up 0.40%, while the emerging companies index rises 0.43% Algerian mining reg...
Read ArticleThe Brisbane-headquartered medtech is drumming up interest in a $20 million placement, cashing in on...
Read ArticleASX health stocks rise in the past five days outperforming broader markets Avita Medical product sa...
Read ArticleShareCafeASX closes 0.4% higher as US futures rise by Peter Milios The S&P/ASX 200 index finis...
Read ArticleASX health stocks fall 0.8% in the past five days in line with broader markets following latest rat...
Read ArticleShareCafeResults from Macquarie & ANZ: ASX 0.11% higher by Peter Milios At noon, the S&P/A...
Read ArticleShareCafeStocks of the Hour: SPT, IPD, MGT Splitit Payments (ASX:SPT, OTCQX...
Read Article05 May 2023 - A snapshot of the stocks on the move featuring Splitit Payments (ASX:SPT), ImpediMed L...
Read ArticleImpediMed gets clearance from the US FDA for its SOZO Pro bioimpedance spectroscopy SOZO Pro offers...
Read ArticleThe ASX is set to extend losses on banking crisis concerns Shares in regional banks PacWest and Wes...
Read ArticleThe ASX is expected to fall on Friday on further fears surrounding the global banking sector — US ba...
Read ArticleASX closes 5 points lower, down 0.08% after a day of ups and downs Goldies are the clear winners ag...
Read ArticleASX health stocks rise 0.97% in the past five days in line with broader markets Impedimed up 99% af...
Read ArticleShareCafeASX closes flat despite rise in US futures by Peter Milios At the closing bell, the S&...
Read ArticleThe ASX saw a shaky rally on Monday, mimicking US futures. The ASX 200 gained 6.8 points to 6962....
Read ArticleBenchmark set to finish close to flat as Energy stocks slump again Goldies are surging again, with...
Read ArticleThe Impedimed Limited (ASX: IPD) share price has had a sensational start to the week. In afternoon...
Read ArticleImpedimed (IPD) shares soar on Monday after the US National Comprehensive Cancer Network (NCCN) reco...
Read ArticleShareCafeEnergy only sector lagging: ASX up 0.27% at noon by Peter Milios At noon, the S&P/ASX...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] A screening platform develo...
Read ArticleImpediMed surges as the US NCCN included bioimpedance spectroscopy (BIS) as part new guidelines Imp...
Read ArticleShareCafeStocks of the Hour: IPD, ALO, GBR ImpediMed (ASX:IPD) announced th...
Read Article27 Mar 2023 - A snapshot of the stocks on the move featuring ImpediMed (ASX:IPD), Alloggio Group (AS...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleASX health stocks fall 1.87% in the past five days as reporting season ends Healius moves to a stat...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ASB)...
Read ArticleThese three S&P/ASX All Ords (ASX: XAO) shares are having a mixed day on the market after the r...
Read ArticleASX health stocks rise 2.27% this week after finishing up 3.9% in January in strong start to 2023...
Read ArticleShareCafeIron ore surge not enough to lift the ASX: Aus shares close 0.16% lower by Peter Milios I...
Read ArticleShareCafeASX down 0.15% at noon despite spike in US markets by Peter Milios The global race for li...
Read ArticleImpediMed (IPD) appoints Richard Valencia as its Managing Director and CEO, effective December 1Curr...
Read ArticleSonic has taken a stake in Microba Immutep enters into second deal with Merck (Germany) and Pfizer ...
Read ArticleShareCafeASX ignores prospect of further COVID restrictions in China, closes 0.59% higher by Peter M...
Read ArticleShareCafeEyes await the new BNPL laws: ASX up 0.57% at noon by Peter Milios The Treasury is expect...
Read ArticleBod Australia returns positive results from Phase 1 trial Paradigm and Impedimed make executive cha...
Read ArticleASX health stocks extend weekly gains on Friday as markets rally on back of promising US inflation...
Read ArticleImpediMed (IPD) extends its clinical trial contract with AstraZeneca for the third timeThe contract...
Read ArticlePharmaxis completes $10 million capital raise, announces positive interim results for Phase II canc...
Read ArticleDuring latest period of volatility many health stocks have seen their share prices remain quite sta...
Read ArticleShareCafeStocks of the Hour: IPD, EFE, VRC ImpediMed (ASX:IPD) this morning...
Read Article04 Oct 2022 - A snapshot of the stocks on the move featuring ImpediMed (ASX:IPD), Eastern Resources...
Read ArticleParadigm successfully meets primary endpoint of Phase 2 trial Immutep granted Fast Track designatio...
Read ArticleMonday was not the start to the week that investors were probably hoping for. By the time the closi...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleMedical software technology company ImpediMed (ASX:IPD) has announced the departure of its m...
Read ArticleImpediMed’s (IPD) Managing Director and CEO, Richard Carreon, resigns after a decade with the compa...
Read ArticleImpediMed (IPD) publishes a paper on the risk factors for breast cancer related lymphoedema Key fin...
Read ArticleThe ASX will open firmer on Monday Wall Street little changed on Friday despite strong US non-farm...
Read ArticleGold aspirant Cavalier Resources announces its new substantial shareholders following IPO Gold stoc...
Read ArticleNordic Nickel announces its new substantial shareholders following its June 2 debut Sigma Healthcar...
Read ArticleASX healthcare stocks finish the week modestly in the green Lumos and Audeara rattle the tin in a b...
Read ArticleHealthcare and life sciences expert Scott Power – a senior analyst with Morgans Financial for 24 yea...
Read ArticleImpediMed (IPD) has welcomed a second contract extension and expansion of its SOZO Digital Health P...
Read ArticleIn this week’s ScoPo’s Powerplays, healthcare and life sciences expert Scott Power, who has been a s...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAt the time of writing, the ASX 200 Health Index (XHJ) is down 2%, while the benchmark ASX 200 is al...
Read ArticleImpediMed (IPD) announces clinical trial agreement for its SOZO platform, which helps patients with...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleImpediMed (IPD) sees its PREVENT Trial results peer-reviewed and published ImpediMed’s study demons...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticleHighlights The rising population and the rise in health issues are increasing the demand for hea...
Read ArticleImpediMed (IPD) completes its share purchase plan, heavily oversubscribed by more than $27 million...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIt was a mixed bag of results for ASX healthcare shares as we walked through October, as some names...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe Impedimed Limited (ASX: IPD) share price has come out of a trading halt today to backtrack mid-...
Read ArticleThe ASX finished in the green by just 0.03%. Today’s gain was spurred by a 1.34% rally in tech share...
Read ArticleMarket watchers interested in the Impedimed Limited (ASX: IPD) share price have woken to another fr...
Read ArticleThe ASX is off to a positive start this week, putting its total gains over the past three weeks up t...
Read ArticleImpediMed is launching a capital raise on Monday morning, on the back of positive clinical trial res...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAs the world emerges from the pandemic, markets are now contending with an energy crisis, a global s...
Read ArticleJust like yesterday the ASX rallied for most of the day but retreated in the afternoon and today clo...
Read ArticleThe Impedimed Limited (ASX: IPD) share price is making good ground today, having climbed 10% from t...
Read ArticleImpediMed (IPD) has rounded off its PREVENT trial, successfully meeting its primary end point in th...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleWall Street mixed as ‘debt ceiling’ deadline approaches US stock markets finished in mixed territori...
Read ArticleThe Impedimed Limited (ASX: IPD) share price is on the move during mid-afternoon trade. This comes...
Read ArticleWall Street mixed to end a volatile week The three US stock marker benchmarks finished the week in m...
Read ArticleWall Street falls again for fourth consecutive day All three major US stock market benchmarks fell o...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((ACF)) - Acrow Formwork and Co...
Read ArticleToday, Thursday the 26th of August, we are happy to buy Lovisa (ASX:LOV), Zip Co Ltd (ASX:Z1P), Oil...
Read ArticleThe Impedimed Limited (ASX: IPD) share price is appreciating after the company released its full-ye...
Read ArticleThe ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index whic...
Read ArticleIDT Australia (ASX:IDT) jumped more than 20% after announcing that it has formalised activities with...
Read ArticleWall Street rose ahead of world centrals banks meeting this week All three US stock market indexes b...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleImpediMed (IPD), The A2 Milk Company (A2M), Unibail-Rodamco-Westfield (URW), Harvey Norman Holdings...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe market is trading near day’s high at the close, after the Reserve Bank of Australia’s (RBA) main...
Read ArticleThe Impedimed Limited (ASX: IPD) share price is bouncing this morning after the company announced p...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe Impedimed Limited (ASX: IPD) share price was off to a flying start this morning, up 13% at mark...
Read ArticleWall Street bounces back All major indices in the US have bounced back, after falling the previous d...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleImpediMed (ASX.IPD) has announced the publication of a peer-reviewed manuscript demonstratin...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe Impedimed Ltd (ASX: IPD) share price shot higher this morning, up 5% in morning trade. This ca...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((3PL)) - 3P Learning ((ALD)) -...
Read ArticleThe Impedimed Limited (ASX: IPD) share price will be closely watched by investors this morning. Thi...
Read ArticleSummary ImpediMed Limited (ASX:IPD) has secured the Health Information Trust Alliance Certificat...
Read ArticleSummary ImpediMed Limited (ASX:IPD) is an emerging contemporary medical technology company that...
Read ArticleSummary ImpediMed Limited (ASX:IPD) has recently announced the publication of meta-analysis. Th...
Read ArticleThe Impedimed Limited (ASX: IPD) share price lifted this morning on positive results from a signifi...
Read ArticleSummary ImpediMed Limited (ASX:IPD) has announced the first order for its SOZO® Digital Health Pl...
Read Article“Program expansion with existing customers is a critical aspect of our growth strategy in the coming...
Read ArticleWorld leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (B...
Read ArticleThe Impedimed Limited (ASX: IPD) share price rocketed by 13.41% today to close the day’s trade at 9...
Read ArticleAstraZeneca has entered an agreement with Australian medical technology company ImpediMed un...
Read ArticleMedical technology company ImpediMed (ASX: IPD) unveiled a timely contract valued at over $2 million...
Read Article“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Austral...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve bee...
Read ArticleParticipating in small cap raises is proving lucrative for investors, with shares in 47 small caps t...
Read ArticlePre-revenue biotech and medtech companies are still not eligible for the Jobkeeper wage subsidy acco...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve kee...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleIt’s still a relatively difficult market to raise capital in, particularly at the junior end, but th...
Read ArticleThe announcement lands just before markets open, ‘the TGA has approved our device’; the buy orders b...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve kee...
Read ArticleMorgans Senior Analyst Scott Power updates the network with information on 3 companies: Volpara (ASX...
Read ArticleImpediMed Limited (ASX:IPD), a medical software technology company that non-invasively measures, mon...
Read ArticleMedical devices company ImpediMed was in the market for fresh equity on Monday night.
Read ArticleShort & Caught is Stockhead’s fortnightly recap of which ASX small cap stocks are heavily shorte...
Read ArticleThe National Comprehensive Care Network (NCCN) has updated its Guidelines for Breast Cancer regardin...
Read ArticleImpediMed (IPD) reports that the national comprehensive care network has recommended that healthcar...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleImpediMed (IPD) has reported increased revenue for the December 2019 quarter Total revenue is up 63...
Read ArticleImpediMed’s (ASX:IPD) December quarter report includes the word ‘up’ eight times and the word ‘down’...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleYou don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the...
Read ArticleThe powerful US Food and Drug Administration (FDA) has cleared a body scanner to check whether a per...
Read ArticleThe ‘software as a service’ (SAAS) business model has taken off in the computer software sector over...
Read ArticleAustralia has an excellent medical research, and health care infrastructure, as a result the Austral...
Read ArticleAustralian Stock Exchange (ASX), a leading stock exchange houses over 2,185 listed entities in its p...
Read ArticleCompanies trading at a price less than $ 1 are classified as penny stocks. These stocks also have a...
Read ArticleIn this week’s recap of substantial shareholders, IOOF and a UK hedge fund manager take a bet they’l...
Read ArticleCanaccord Genuity and Wilsons are in the market with an equity raising for ImpediMed.
Read ArticleThe healthcare sector might be in for some merger and acquisition action, as cashed-up companies in...
Read ArticleCV Check Ltd CV Check Ltd (ASX: CV1) is a leading online integrated screening and verification compa...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
